Wei Shi

No ORCID on file · 40 papers in corpus · active 2015-2026

Study types

  • article 14
  • dataset 12
  • other 6
  • preprint 4
  • review 3

Condition tags

  • adenomyosis 29
  • endometriosis 6
  • mesh:D004715 5
  • infertility 2
  • dysmenorrhea 1
  • mesh:D004412 1
preprint 2026
·doi:10.21203/rs.3.rs-8294770/v1
other 2026
BMC women's health ·doi:10.1186/s12905-026-04415-0

BACKGROUND: Synchronous multiple primary malignancies (SMPMs) involving the uterus and ovary pose significant diagnostic challenges, particularly in distinguishing independent primary tumors from metastatic disease when tumors exhibit overl…

review 2026
International journal of molecular medicine ·doi:10.3892/ijmm.2026.5778

Adenomyosis (AM), an estrogen‑dependent chronic inflammatory disease with a rising incidence, has emerged as a major cause of infertility and reduced clinical pregnancy rates in reproductive‑aged women, severely impairing reproductive healt…

article 2026
·doi:10.70976/j.1008-0805.szgygy-2026-0205

目的 探讨桂枝-重楼有效成分联用抑制子宫腺肌病(AM)进展的相关分子机制。 方法 利用梯度浓度的重楼皂苷(PP)I、II、VII(PPI、PPII、PPVII)及桂枝有效成分反式肉桂醛(TCA)分别处理子宫腺肌病原代细胞(AMDC),通过CCK-8法检测药物对AMDC活力的影响;正交实验筛选PPII与TCA最佳配比(简称PT),Transwell检测细胞侵袭、迁移能力;网络药理学筛选出PT治疗AM的关键通路;利用梯度浓度的PT腹腔注射ICR小鼠30 d,评价药物的安全性…

article 2026
·doi:10.1007/s00281-026-01077-w

Adenomyosis is a common and difficult disease in gynecology. Its main clinical manifestations include uterine hypertrophy, excessive menstruation, pelvic pain and infertility, which have a serious impact on women's health. Seriously affects…

article 2025
Journal of reproductive immunology ·doi:10.1016/j.jri.2025.104551

This study aimed to explore the causal link between immunophenotypes and adenomyosis using Mendelian randomization (MR). We conducted a bidirectional MR analysis on 731 immunophenotypes, employing inverse-variance weighted (IVW) as the prim…

article 2025
Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/j.reprotox.2025.109024
other 2025
Hereditas ·doi:10.1186/s41065-025-00590-6

BACKGROUND: Endometriosis (EMs), a common gynecological disorder, involves complex molecular mechanisms. Metabolic reprogramming (MR) has been recognized as a hallmark of EMs, contributing to lesion survival and immune microenvironment remo…

article 2025
Phytomedicine : international journal of phytotherapy and phytopharmacology ·doi:10.1016/j.phymed.2025.157748
preprint 2025
·doi:10.2139/ssrn.5517124
article 2024
Phytomedicine : international journal of phytotherapy and phytopharmacology ·doi:10.1016/j.phymed.2024.155461

BACKGROUND: The active ingredients of the Chinese medical herb Paris polyphylla, P. polyphylla ethanol extract (PPE) and polyphyllin I (PPI), potentially inhibit epithelial-mesenchymal transition (EMT) in tumors. However, the roles of these…

article 2023
·doi:10.2340/actadv.v103.12425

Alopecia areata is an autoimmune disorder that greatly impacts patients' quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively st…

article 2023
Tissue & cell ·doi:10.1016/j.tice.2023.102284

Because adenomyosis (AM) ectopic primary cells are hard to come by, have a short lifespan, and the characteristics that alter over time, their utility in AM research is constrained. This study aimed to establish a line of immortalized human…

article 2023
Journal of inflammation research ·doi:10.2147/jir.s402734

Purpose: Adenomyosis (AM) is a common benign uterine disorder that has deleterious effects on women's health. However, the pathogenesis of AM is not clearly understood. We aimed to investigate the pathophysiological changes and molecular me…

other 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/6350257

BACKGROUND: The effect of GuizhiFuling Wan (GFW) on adenomyosis (AM) is definite. This study aimed to explore the mechanism and key therapeutic targets of GFW in treating AM through network pharmacology combined with molecular docking and e…

article 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/2624434

Objective: Sm. (C-P) drug pair in the treatment of adenomyosis (AM) based on network pharmacology and animal experiments. Methods: Via a network pharmacology strategy, a drug-component-target-disease network (D-C-T-D) and protein-protein in…

preprint 2022
·doi:10.22541/au.165519364.49734412/v1

Some of the key steps in adenomyosis (AM) are the migration and invasion of adenomyosis derived cells (AMDC); these processes require rearrangement of the cytoskeleton which Rho/ROCK signaling pathway is involved. The aim of the current stu…

dataset 2021
·doi:10.6084/m9.figshare.14183837

Additional file 1: Figure S1. HE staining and QC. (A) Samples from the AM_CTRL, AM_EM and AM_EC groups were HE stained, and the black arrow shows the gland invading the muscular layer. (B) X axis represents the number of UMI in each cell, a…

dataset 2021
·doi:10.6084/m9.figshare.14183837.v1

Additional file 1: Figure S1. HE staining and QC. (A) Samples from the AM_CTRL, AM_EM and AM_EC groups were HE stained, and the black arrow shows the gland invading the muscular layer. (B) X axis represents the number of UMI in each cell, a…

dataset 2021
·doi:10.6084/m9.figshare.14183840

Additional file 2: Table S1. Doublet score and predicted doublets.

dataset 2021
·doi:10.6084/m9.figshare.14183840.v1

Additional file 2: Table S1. Doublet score and predicted doublets.

dataset 2021
·doi:10.6084/m9.figshare.14183843.v1

Additional file 3: Table S2. DEGs of AM_EC vs. AM_EM (all cell types).

dataset 2021
·doi:10.6084/m9.figshare.14183843

Additional file 3: Table S2. DEGs of AM_EC vs. AM_EM (all cell types).

dataset 2021
·doi:10.6084/m9.figshare.14183846.v1

Additional file 4: Table S3. Coexisting genes in Venn.

dataset 2021
·doi:10.6084/m9.figshare.14183846

Additional file 4: Table S3. Coexisting genes in Venn.